David S. Hong MD
@DavidHongMD
Followers
4K
Following
6K
Media
322
Statuses
2K
MD Anderson Cancer Center medical oncologist, Deputy Chair of Dept. Investigational Cancer Therapeutics. Phase I clinical trials.Tweets are mine.
Houston, TX
Joined February 2016
I need to learn mandrin! š.
Had a conversation with someone outside of healthcare recently who was shocked by how long it takes to run clinical trials in the U.S (not to mention expensive). I tried to explaināitās not just the science. Itās the infrastructure. Every site needs dozens of personnel, many of
2
1
8
RT @GIMedOnc: Had a conversation with someone outside of healthcare recently who was shocked by how long it takes to run clinical trials inā¦.
0
46
0
Yep! I say we just have the drug development session at ASCO in Mandarin š.
China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. @IQVIA_global .
1
3
19
If you are ever in Minnetonka, MN and ever need to goto the best steakhouse in the MN stop by Gianniās! Terriās Mark Fox was a wonderful pt of mine on a 1st in human trial and both their sacrifice will impact future pts to come! (shared with permission)!
0
1
17
Truth!.
Dads. 1. The world's full of experts, but nobody teaches you like Dad does.
0
1
2
RT @OncLive: In a interview, @DavidHongMD detailed:.āļø The implications of the full FDA approval of larotrectinib.āļø His experience adminisā¦.
0
2
0
Congrats to Dr Tara Davidson, and Dr Derrick Tao and missing in this picture Dr Kunwha Kim for finishing your Med Onc fellowship at @MDAndersonNews! It was an honor to have mentored you all! God Speed and God Bless! I look forward to your success!
1
1
36
RT @fireflyann: A Phase 1/ā2a Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors.NCT07020221.Sites in TN, TX and WA. https://tā¦.
0
1
0
RT @springermeded: Discover best pathologic practices within NSCLC and thyroid cancer, as well as insights into how genomic testing can impā¦.
0
5
0
The Legend @Dr_R_Kurzrock !.
After over a decade, got to visit and give precision medicine grand rounds for John Moroney, who now heads the Gyne Onc section at University of Chicago. Still remember our conversations at MD Anderson. We both recall the same patients. Time flies. Nice to reconnect.
0
0
5
0
4
0
What!!!?š³.
Shocking data š¤Æ. Effect size is huge, way larger than expected. Urgent to seek reproduction/validation of the finding in further studies, given the potential implications on clinical practice and clinical trials (across oncology fields).
0
1
8
RT @oncology_bg: The most practice changing trial from #ASCO25 is now live on @NEJM .If this was a drug, this would be approved today. Globā¦.
0
301
0
Check out the first PDL-1/PDL-2 bispecific in trials in progress poster of IMGS-001 from Immunogenesis -poster board 324a!
0
2
5
Sanjay if you start a show I will be your first guest! @DrSanjayPopat funniest man in Oncology!.
Awesome to bump into the great Drs Yap and Shiu at #ASCO25. A real pleasure to discuss all things oncology! Just missing @DavidHongMD
0
0
2
RT @MDAndersonNews: Presented by Dr. Tim Yap at #ASCO25: BNT142, a bispecific antibody therapy, shows manageable safety and early anti-tumoā¦.
0
8
0
The philosopher!.
HMPL-306, a novel small-molecular dual inhibitor of IDH1 and IDH2 mutations is safe and well tolerated and showed durable responses in patients with lower-grade gliomas, says our Dr. Jordi Rodon Ahnert in an oral presentation at #ASCO25. @ASCO #EndCancer
0
0
5